Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.
Blood Cancer Discovery|August 8, 2025
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic LeukemiaHaley Newman, Shawn H R Lee, Petri Pölönen, et al.
Cancer Research|March 11, 2016
Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemiaSibasish Dolai, Keith C S Sia, Alissa K Robbins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2019
Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic MalignancyAlix E Seif, Yimei Li, Dimitri S Monos, et al.
Blood|June 5, 2015
Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoproteinHaiying Qin, Monica Cho, Waleed Haso, et al.
Molecular Genetics and Metabolism|July 5, 2022
Hematologic abnormalities in Aicardi Goutières SyndromeLaura A Adang, Francesco Gavazzi, Russell D'Aiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic LeukemiaCaner Saygin, Giorgia Giordano, Kathryn Shimamoto, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood|February 4, 2015
Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemiaShannon L Maude, Sibasish Dolai, Cristina Delgado-Martin, et al.
The Lancet. Haematology|September 24, 2021
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trialsAllison Barz Leahy, Haley Newman, Yimei Li, et al.
Pageof 21